動物用抗生物質・抗菌薬の市場規模、シェア、成長分析、タイプ別、送達別、動物別、地域別 - 産業予測、2025～2032年

動物用抗生物質・抗菌薬の市場規模は2023年に46億2,000万米ドルと評価され、2024年の47億8,000万米ドルから2032年には63億米ドルに成長し、予測期間（2025-2032年）のCAGRは3.5%で成長する見通しです。

2023年10月現在、世界の動物用抗生物質・抗菌薬市場は動物用医薬品部門にとって極めて重要であり、主に動物性タンパク質の需要急増がその原動力となっています。世界人口の増加と可処分所得の増加により、肉、牛乳、卵の消費量が増加し、結果として家畜の生産量が増加しています。この成長により、家畜の伝染病予防と治療のために抗生物質や抗菌剤の使用が必要となります。さらに、呼吸器感染症や胃腸感染症などの有病率の上昇は、効果的な疾病管理の必要性を強調しています。動物福祉と人獣共通感染症トランスミッションの予防への関心の高まりは、動物の健康、最適な成長、生産性を確保する上で、これらの医薬品の重要性をさらに強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

動物用抗生物質・抗菌薬市場規模：タイプ別

• 市場概要
• テトラサイクリン
• ペニシリン
• スルホンアミド
• マクロライド
• アミノグリコシド
• リンコサミド
• フルオロキノロン
• セファロスポリン
• その他の抗菌剤および抗生物質

動物用抗生物質・抗菌薬市場規模：送達別

• 市場概要
• プレミックス
• 経口パウダー
• 経口液剤
• 注射
• その他

動物用抗生物質・抗菌薬市場規模：動物別

• 市場概要
• 食用動物
  • 牛
  • 豚
  • 家禽
  • 羊とヤギ
  • その他の食用動物
• コンパニオンアニマル
  • 犬
  • 猫
  • 馬
  • その他のペット

動物用抗生物質・抗菌薬市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
• 収益の前年比比較（2022-2024）

主要企業プロファイル

• Zoetis Inc.（USA）
• Merck & Co., Inc.（USA）
• Elanco Animal Health Incorporated（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Vetoquinol（France）
• Bayer AG（Germany）
• Novartis AG（Switzerland）
• Eli Lilly and Company（USA）
• Sanofi（France）
• Intervet Inc.（Netherlands）
• Alltech（Ireland）
• Huvepharma（Bulgaria）
• Kemin Industries（USA）
• Novus International（USA）
• Biomin Holding GmbH（Austria）
• ADM Animal Nutrition（USA）
• Adisseo（France）
• DSM（Netherlands）

結論と推奨事項

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.62 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 6.3 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

As of October 2023, the global animal antibiotics and antimicrobials market is crucial to the veterinary pharmaceutical sector, primarily driven by the surging demand for animal protein. The increase in the global population and growing disposable incomes has led to higher consumption of meat, milk, and eggs, consequently boosting livestock production. This growth necessitates the use of antibiotics and antimicrobials for the prevention and treatment of infectious diseases among animals. Additionally, the rising prevalence of conditions such as respiratory and gastrointestinal infections emphasizes the need for effective disease management. The heightened focus on animal welfare and the prevention of zoonotic disease transmission further underscores the importance of these pharmaceuticals in ensuring animal health, optimal growth, and productivity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Antibiotics And Antimicrobials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Antibiotics And Antimicrobials Market Segmental Analysis

Global Animal Antibiotics And Antimicrobials Market is segmented by type, delivery, animal and region. Based on type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Based on delivery, the market is segmented into premixes, oral powder, oral solution, injection and others. Based on animal, the market is segmented into food-producing animals and companion animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is significantly driven by the emergence of infectious diseases in livestock, including avian influenza, foot-and-mouth disease, and swine fever. These outbreaks highlight the critical need for effective antibiotics and antimicrobials to manage and prevent disease proliferation. The potential economic fallout from such epidemics spurs increased demand for these products, especially in areas where these diseases are frequently encountered. This demand is primarily fueled by the urgent need to safeguard animal health and ensure sustained productivity within the livestock sector, making these pharmaceuticals essential for maintaining the integrity of animal farming operations.

Restraints in the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market faces significant restraints due to changing consumer preferences towards antibiotic-free products. As awareness around food safety and sustainability continues to grow, there is a rising demand for animal products that do not involve the use of antibiotics. This shift in consumer behavior has prompted producers to transition toward antibiotic-free production methods, negatively affecting the demand for traditional animal antibiotics and antimicrobials. In their efforts to align with market trends and meet consumer expectations, producers are increasingly exploring alternative strategies for disease prevention and growth promotion in livestock, emphasizing sustainability and the reduction of antibiotic use.

Market Trends of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is witnessing a significant trend towards the adoption of antibiotic alternatives, fueled by growing concerns over antimicrobial resistance (AMR) and its implications for both animal and human health. Regulatory pressures, heightened consumer awareness, and industry initiatives are driving the reduction of traditional antibiotic use in livestock production. Consequently, alternatives such as probiotics, prebiotics, phytogenics, and vaccines are emerging as effective solutions to promote animal well-being while minimizing AMR risks. This shift reflects a broader commitment within the industry to enhance animal health, optimize production efficiency, and adhere to responsible usage practices in veterinary medicine, shaping the future of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Antibiotics And Antimicrobials Market Size by Type & CAGR (2025-2032)

• Market Overview
• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials And Antibiotics

Global Animal Antibiotics And Antimicrobials Market Size by Delivery & CAGR (2025-2032)

• Market Overview
• Premixes
• Oral Powder
• Oral Solution
• Injection
• Others

Global Animal Antibiotics And Antimicrobials Market Size by Animal & CAGR (2025-2032)

• Market Overview
• Food-Producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep And Goats
  • Other Food-Producing Animals
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Global Animal Antibiotics And Antimicrobials Market Size & CAGR (2025-2032)

• North America (Type, Delivery, Animal)
  • US
  • Canada
• Europe (Type, Delivery, Animal)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Animal)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Animal)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Animal)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet Inc. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomin Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Animal Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations